Jin Seok Ahn

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

Ji‐Youn Han, Keunchil Park, Sang‐We Kim et al. · Journal of Clinical Oncology · 2012 · 732 citations

Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer

Joon Oh Park, Sang‐We Kim, Jin Seok Ahn et al. · Journal of Clinical Oncology · 2007 · 181 citations · Full text

Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy

Dae Ho Lee, Keunchil Park, Joo Hang Kim et al. · Clinical Cancer Research · 2010 · 176 citations · Full text

Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung Cancer

Sarah Park, Alison J. Holmes-Tisch, Eun Yoon Cho et al. · Journal of Thoracic Oncology · 2009 · 146 citations · Full text

Molecular Biomarkers, Medicine, Cancer Growth +11

Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherapy

Jong‐Mu Sun, Joungho Han, Jin Seok Ahn et al. · Journal of Thoracic Oncology · 2011 · 122 citations